A Study of JNJ-77242113 for the Treatment of Participants With Generalized Pustular Psoriasis or Erythrodermic Psoriasis
Clinical trial NCT06295692 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06295692
- Sponsor
- Janssen Pharmaceutical K.K.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-09
- Primary completion
- 2025-01-14
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.